Unit Converter
Kappa (κ) light chain
Synonyms
- Kappa free light chain (κ-FLC)
- Free κ light chain
- Serum free light chain (κ)
- κ immunoglobulin light chain
- Kappa monoclonal protein
- Bence–Jones kappa light chain (urine)
Units of Measurement
- g/L
- mg/dL
- mg/100 mL
- mg%
- mg/mL
Key Conversions
1 mg/dL = 0.01 g/L
1 mg/mL = 1 g/dL = 10 g/L
mg% = mg/dL = mg/100 mL
Free light chains are measured by mass, not molar units.
Description
Kappa light chains are immunoglobulin light chains produced by plasma cells.
Each immunoglobulin molecule contains:
- 2 heavy chains
- 2 light chains (either κ or λ)
“Free light chains (FLC)” refer to κ or λ chains not attached to intact immunoglobulin.
These circulate freely and are:
- Filtered by kidneys
- Catabolized by proximal tubular cells
Measurement of serum free κ light chain is essential in diagnosing:
- Multiple myeloma
- Light chain myeloma
- MGUS
- AL amyloidosis
- Kidney involvement in plasma cell disorders
Physiological Role
Normal Production
Plasma cells produce slightly more κ than λ light chains, resulting in:
- κ:λ ratio ~0.26–1.65
Kidney Clearance
- Free light chains filtered by glomeruli
- Reabsorbed in proximal tubules
- Elevated in renal impairment
Immunological Role
When attached to heavy chains, they form intact immunoglobulins (IgG, IgA, IgM, etc.)
Clinical Significance
HIGH Kappa Light Chains
Elevated κ free light chains (with or without abnormal ratio) indicate:
1. Multiple Myeloma (MM)
Especially:
- Light chain myeloma
- Oligosecretory myeloma
- Non-secretory myeloma evolving to light chain production
Diagnostic clues:
- High κ
- Abnormal κ/λ ratio
- Abnormal SPEP/UPEP
- Monoclonal spike
2. MGUS (Monoclonal Gammopathy of Undetermined Significance)
Abnormal κ or λ with mildly altered ratio.
3. AL Amyloidosis
κ or λ light chains deposit in tissues → organ dysfunction.
4. Plasmacytoma or Other Plasma Cell Neoplasms
Isolated production of κ free light chain.
5. Renal Failure
Reduced clearance → κ and λ both rise but ratio usually remains normal.
6. Autoimmune or Inflammatory Diseases
Mild κ elevation may occur due to polyclonal activation.
LOW Kappa Light Chains
Low κ free light chain alone is rarely clinically important except as:
- Indicator of plasma cell suppression
- Finding after chemotherapy
- Indicator of immunosuppression or immunodeficiency
Reference Intervals
Adults
- Free κ Light Chain: 3.3 – 19.4 mg/L
(= 0.0033 – 0.0194 g/L)
κ/λ Ratio
- Reference ratio: 0.26 – 1.65
Critical for interpretation.
In Renal Impairment
Kappa rises to:
- 10 – 40 mg/L, but ratio remains often <3.0
Myeloma Diagnostic Cutoffs
- κ > 100 mg/L with abnormal ratio → significant monoclonal process
- κ/λ ratio > 100 strongly suggests light chain myeloma
Diagnostic Uses
1. Multiple Myeloma Workup
κ FLC elevation + abnormal κ/λ ratio → monoclonal κ clone.
2. MGUS Monitoring
Abnormal κ/λ ratio predicts progression risk.
3. AL Amyloidosis Diagnosis
κ or λ elevation + clinical organ involvement.
4. Light Chain Cast Nephropathy
High κ → kidney tubular damage.
5. Renal Function Assessment in Myeloma
κ levels reflect renal clearance when both chains elevated.
6. Oligosecretory & Non-Secretory Myeloma
FLC assay is the only marker for disease monitoring.
7. Post-Treatment Monitoring
Chemotherapy response tracked by decline in κ FLC levels.
Analytical Notes
- Serum (not plasma) recommended
- Free light chain assays vary by manufacturer
- Renal impairment elevates both κ & λ → interpret ratio carefully
- SPEP, UPEP, and immunofixation are complementary tests
- Serial monitoring more reliable than single value
Clinical Pearls
- κ/λ ratio is more important than the absolute level.
- In renal failure, κ and λ both rise but ratio remains near normal.
- κ >100 mg/L + abnormal ratio qualifies as a myeloma-defining event (IMWG).
- Light chain myeloma may have little or no M-spike on SPEP—FLC is essential.
- Urine tests detect Bence–Jones proteins, but serum FLC is more sensitive.
Interesting Fact
Free light chains are produced at a rate of 500 mg/day, but most are rapidly cleared by kidneys-making renal function a major determinant of serum levels.
References
- Tietz Clinical Chemistry & Molecular Diagnostics, 8th Edition - Immunoglobulins & Light Chains
- International Myeloma Working Group (IMWG) Guidelines
- Mayo Clinic Laboratories - Serum Free Kappa Light Chains
- ARUP Consult - Plasma Cell Dyscrasias
- Blood / Lancet Hematology Reviews - Free Light Chains
- MedlinePlus / NIH - Light Chain Tests